Advertisement

Medicinal Chemistry Research

, Volume 20, Issue 9, pp 1445–1449 | Cite as

Drug discovery against H1N1 virus (influenza A virus) via computational virtual screening approach

  • Ashwani Sharma
  • Ashish V. Tendulkar
  • Pramod P. WangikarEmail author
Original Research

Abstract

The H1N1 virus is the causative agent of the recent outbreak of Swine flu pandemic. Neuraminidase is an enzyme that cleave glycosidic linkage of neuraminic acid on viral cell surface and is known to occur as antigen determinant to evoke immune response in host cell. It plays an important role in life cycle of influenza virus. Inhibitors of neuraminidase are, therefore, believed to have a potential in development of new drugs against swine flu. Using a recently published model structure of neuraminidase, we have carried out virtual screening of 70 compounds obtained from Ligand databases. The ligands library also included 57 natural plant metabolites from medicinal plants. The virtual screening was performed via PatchDock & GemDock softwares. Two of the plant metabolites, Hesperidin & Narirutin showed significantly higher docking score than the currently marketed anti-influenza drug Oseltamivir (Tamiflu).

Keywords

H1N1 influenza virus Swine flu Antiviral compound Docking Oseltamivir (Tamiflu) Hesperidin Narirutin 

Notes

Acknowledgments

Ashwani Sharma is grateful to Council of Scientific and Industrial Research (CSIR) for his research fellowship. Ashish V. Tendulkar gratefully acknowledges support from Department of Biotechnology Govt. of India through Innovative Young Biotechnologist Award 2008.

Supplementary material

44_2010_9375_MOESM1_ESM.xls (28 kb)
Supplementary material 1 (XLS 28 kb)

References

  1. Baum SG (2009) Oseltamivir resistance: what does it mean clinically? Clin Infect Dis 49:1836–1837PubMedCrossRefGoogle Scholar
  2. Butler D (2009) Swine flu goes global. Nature 458:1082–1083PubMedCrossRefGoogle Scholar
  3. Cohen J, Enserink M (2009) As swine flu circles globe, scientists grapple with basic questions. Science 324:572–573PubMedCrossRefGoogle Scholar
  4. Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, Walker PA, Martin SR, Daniels RS, Gregory V, Skehel JJ, Gamblin SJ, Hay AJ (2009) Structural basis for oseltamivir resistance of influenza viruses. Vaccine 27:6317–6323PubMedCrossRefGoogle Scholar
  5. Dalakouras T, Smith BJ, Platis D, Cox MMJ, Labrou NE (2006) Development of recombinant protein-based influenza vaccine. Expression and affinity purification of H1N1 influenza virus neuraminidase. J Chromatogr A 1136:48–56PubMedCrossRefGoogle Scholar
  6. Kou Z, Li Y, Yin Z, Guo S, Wang M, Gao X, Li P, Tang L, Jiang P, Luo Z, Xin Z, Ding C, He Y, Ren Z, Cui P, Zhao H, Zhang Z, Tang S, Yan B, Lei F, Li T (2009) The survey of H5N1 flu virus in wild birds in 14 provinces of China from 2004 to 2007. PLoS ONE 4(9):1–8CrossRefGoogle Scholar
  7. Manzoni M, Colombi P, Papini N, Rubaga L, Tiso N, Preti A, Venerando B, Tettamanti G, Bresciani R, Argenton F, Borsani G, Monti E (2007) Molecular cloning and biochemical characterization of sialidases from zebrafish (Danio rerio). Biochem J 408:395–406PubMedCrossRefGoogle Scholar
  8. Maurer-Stroh S, Ma J, Lee RTC, Sirota FL, Eisenhaber F (2009) Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites. Biol Direct 4:1–9CrossRefGoogle Scholar
  9. Ooi HS, Kwo CY, Wildpaner M, Sirota FL, Eisenhaber B, Maurer-Stroh S, Wong WC, Schleiffer A, Eisenhaber F, Schneider G (2009) ANNIE: integrated de novo protein sequence annotation. Nucl Acids Res 37:W435–W440PubMedCrossRefGoogle Scholar
  10. Petrosillo N, Di Bella S, Drapeau C, Grilli E (2009) The novel influenza A (H1N1) virus pandemic: an update. Ann Thorac Med 4:163–172PubMedCrossRefGoogle Scholar
  11. Saha RK, Takahashi T, Suzuki T (2009) Glucosyl hesperidin prevents influenza A virus replication in vitro by inhibition of viral sialidase. Biol Pharm Bull 32:1188–1192PubMedCrossRefGoogle Scholar
  12. Schirmer P, Holodniy M (2009) Oseltamivir for treatment and prophylaxis of influenza infection. Expert Opin Drug Saf 8:357–371PubMedCrossRefGoogle Scholar
  13. Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ (2005) PatchDock and SymmDock: servers for rigid and symmetric docking. Nucl Acids Res 33:W363–W367PubMedCrossRefGoogle Scholar
  14. Schnitzler SU, Schnitzler P (2009) An update on swine-origin influenza virus A/H1N1: a review. Virus Genes 39:279–292PubMedCrossRefGoogle Scholar
  15. Smith GJD, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JSM, Guan Y, Rambaut A (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122–1125PubMedCrossRefGoogle Scholar
  16. Taube S, Perry JW, Yetming K, Patel SP, Auble H, Shu L, Nawar HF, Chang HL, Connell TD, Shayman JA, Wobus CE (2009) Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine noroviruses. J Virol 83:4092–4101PubMedCrossRefGoogle Scholar
  17. Thomson RJ, Haselhorst T, Dyason JC, Von Itzstein M (2009) Cracking the code for H5N1-bird flu and beyond. Curr Drug Deliv 6:343–346PubMedCrossRefGoogle Scholar
  18. Uyeki TM (2009) Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 49:279–290PubMedCrossRefGoogle Scholar
  19. Wang X, Jia W, Zhao A, Wang X (2006) Anti-influenza agents from plants and traditional Chinese medicine. Phytother Res 20:335–341PubMedCrossRefGoogle Scholar
  20. Yang JM, Chen CC (2004) GEMDOCK: a generic evolutionary method for molecular docking. Proteins Struct Funct Genet 55:288–304PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Ashwani Sharma
    • 1
  • Ashish V. Tendulkar
    • 2
  • Pramod P. Wangikar
    • 3
    Email author
  1. 1.Department of Bioscience and BioengineeringIndian Institute of Technology BombayMumbaiIndia
  2. 2.Department of Computer Science and EngineeringIndian Institute of Technology MadrasChennaiIndia
  3. 3.Department of Chemical EngineeringIndian Institute of Technology BombayMumbaiIndia

Personalised recommendations